Log in to save to my catalogue

The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin...

The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1826675717

The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis

About this item

Full title

The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis

Publisher

England: Lippincott Williams & Wilkins, a business of Wolters Kluwer Health

Journal title

European journal of cancer prevention, 2017-01, Vol.26 (1), p.78-85

Language

English

Formats

Publication information

Publisher

England: Lippincott Williams & Wilkins, a business of Wolters Kluwer Health

More information

Scope and Contents

Contents

To assess the current evidence on the potential benefit of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) on cancer recurrence and survival, we comprehensively searched PubMed, Embase, and the Cochrane Library from their inception to April 2013. Two authors screened out duplicates and independently reviewed...

Alternative Titles

Full title

The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1826675717

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1826675717

Other Identifiers

ISSN

0959-8278

E-ISSN

1473-5709

DOI

10.1097/cej.0000000000000269

How to access this item